Cite
HARVARD Citation
Modest, D. et al. (2017). FOLFOXIRI plus bevacizumab as conversion-therapy for liver metastases in colorectal cancer: A necessity?. European journal of cancer. pp. 71-73. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Modest, D. et al. (2017). FOLFOXIRI plus bevacizumab as conversion-therapy for liver metastases in colorectal cancer: A necessity?. European journal of cancer. pp. 71-73. [Online].